Before using EMA, we were paper based. Our use of EMA became exponentially
more efficient once we partnered with Miraca. We like the seamless integration
of path reports. So instead of needing to find a paper report and scan
it into EMA, the results integrate right into the chart.
The patient experience is very different since using the EMR. Instead
of running around when the patient arrives for suture removal—‘Where’s
their path? Is it pulled? Is it in their chart? Is it in a pile? Is it
in a folder?’—we simply now pull it up on the desktop. And
we get fewer phone calls from the [Miraca] pathologists, because the company
that we used before would call us: ‘What was the morphology? What
did it look like? Is it a rash? Is this is lesion? What are you trying
to rule out?’ And now that we can send [our] notes to the lab, we
get fewer calls from [Miraca] dermatopathologists.
If you’re not on EMA, you should get EMA—it’s wonderful.
And if you’re using EMA, you sure should be using Miraca. I can’t
express enough how helpful Miraca has been to us.